Ethyl 3-[(2-{[4-((hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate methanesulphonate
PK140585AUndetermined Publication Date: 2010-03-30BOEHRINGER INGELHEIM INT GMBH
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200900277
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-03-30
Abstract
The present invention relates to the compound ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate methanesulphonate in the crystalline modification I as the hemihydrate and the use thereof as a pharmaceutical composition.
Need to check novelty before this filing date? Find Prior Art